Feedback
STAR 
Reputation: 642,713 • Sep 15, 2023 3:28 PM
Strides Pharma up 4% as arm receives tentative USFDA approval for Dolutegravir tablets
The products will be manufactured at the company’s facility in Bengaluru and conversion of this tentative approval to a full approval is expected upon expiry of the constraining patents.
Moneycontrol
2 Votes
Comment
2 Shares
NSE:STAR price when posted: 514.7
View Votes